4,5-MDO-DiPT: Difference between revisions
Appearance
Content deleted Content added
→Categorization: unnecessary |
Entranced98 (talk | contribs) Importing Wikidata short description: "Chemical compound" |
||
(16 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{chembox |
|||
{{Infobox drug |
|||
| verifiedrevid = 455012632 |
|||
| |
| drug_name = 4,5-MDO-DiPT |
||
| image = 4,5-MDO-DiPT.svg |
|||
| ImageSize = 200px |
|||
| |
| width = |
||
| caption = |
|||
⚫ | |||
| Section1 = {{Chembox Identifiers |
|||
<!-- Clinical data --> |
|||
⚫ | |||
| |
| pronounce = |
||
| |
| tradename = |
||
| |
| Drugs.com = |
||
| MedlinePlus = |
|||
| Section2 = {{Chembox Properties |
|||
| licence_CA = |
|||
| Formula = C<sub>17</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub> |
|||
| licence_EU = |
|||
| MolarMass = 288.39 g/mol |
|||
| |
| DailyMedID = |
||
| |
| licence_US = |
||
| |
| pregnancy_AU = |
||
| |
| pregnancy_category = |
||
| dependency_liability = |
|||
| Solubility = }} |
|||
| addiction_liability = |
|||
| Section3 = {{Chembox Hazards |
|||
| routes_of_administration = |
|||
| MainHazards = |
|||
| |
| class = |
||
| |
| ATC_prefix = |
||
| ATC_suffix = |
|||
<!-- Legal status --> |
|||
| legal_status = |
|||
<!-- Pharmacokinetic data --> |
|||
| bioavailability = |
|||
| protein_bound = |
|||
| metabolism = |
|||
| metabolites = |
|||
| onset = |
|||
| elimination_half-life = |
|||
| duration_of_action = |
|||
| excretion = |
|||
<!-- Identifiers --> |
|||
| CAS_number = 82173-82-8 |
|||
| CAS_supplemental = |
|||
⚫ | |||
| UNII = VTE2RS8757 |
|||
| PubChem = 44383444 |
|||
| IUPHAR_ligand = |
|||
| DrugBank = |
|||
| ChemSpiderID = 23511907 |
|||
| KEGG = |
|||
| ChEBI = |
|||
| ChEMBL = 352315 |
|||
| NIAID_ChemDB = |
|||
| PDB_ligand = |
|||
⚫ | |||
<!-- Chemical data --> |
|||
| IUPAC_name = N-[2-(6H-[1,3]dioxolo[4,5-e]indol-8-yl)ethyl]-N-propan-2-ylpropan-2-amine |
|||
| C=17 | H=24 | N=2 | O=2 |
|||
| SMILES = CC(C)N(CCC1=CNC2=C1C3=C(C=C2)OCO3)C(C)C |
|||
| StdInChI = 1S/C17H24N2O2/c1-11(2)19(12(3)4)8-7-13-9-18-14-5-6-15-17(16(13)14)21-10-20-15/h5-6,9,11-12,18H,7-8,10H2,1-4H3 |
|||
| StdInChIKey = PTYYWSKZYOSFEK-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''4,5-MDO-DiPT''', or '''4,5-[[methylenedioxy]]-N,N-di[[isopropyl]][[tryptamine]]''', is a lesser-known [[Psychedelics, dissociatives and deliriants|psychedelic drug]]. It is the 4,5-[[methylene]]di[[oxy]] [[analog (chemistry)|analog]] of [[DiPT]]. 4,5-MDO-DiPT was first synthesized by [[Alexander Shulgin]]. In his book ''[[TiHKAL]]'' (''Tryptamines I Have Known and Loved''), 4,5-MDO-DiPT produces slight [[LSD]]-like effects after several hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of 4,5-MDO-DiPT. |
'''4,5-MDO-DiPT''', or '''4,5-[[methylenedioxy]]-N,N-di[[isopropyl]][[tryptamine]]''', is a lesser-known [[Psychedelics, dissociatives and deliriants|psychedelic drug]]. It is the 4,5-[[methylene bridge|methylene]]di[[Oxygen|oxy]] [[analog (chemistry)|analog]] of [[DiPT]]. 4,5-MDO-DiPT was first synthesized by [[Alexander Shulgin]]. In his book ''[[TiHKAL]]'' (''Tryptamines I Have Known and Loved''), 4,5-MDO-DiPT produces slight [[LSD]]-like effects after several hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of 4,5-MDO-DiPT. |
||
== See also == |
== See also == |
||
* [[1-(2-Dimethylaminoethyl)dihydropyrano(3,2-e)indole|4,5-DHP-DMT]] |
* [[1-(2-Dimethylaminoethyl)dihydropyrano(3,2-e)indole|4,5-DHP-DMT]] |
||
* [[4,5-MDO-DMT]] |
* [[4,5-MDO-DMT]] |
||
* [[5,6-MDO-DiPT]] |
|||
* [[Tryptamine]] |
* [[Tryptamine]] |
||
* [[DiPT]] |
* [[DiPT]] |
||
Line 37: | Line 75: | ||
* [http://tihkal.info/read.php?domain=tk&id=28 4,5-MDO-DIPT Entry in TiHKAL • info] |
* [http://tihkal.info/read.php?domain=tk&id=28 4,5-MDO-DIPT Entry in TiHKAL • info] |
||
{{ |
{{Tryptamines}} |
||
[[Category:Psychedelic tryptamines]] |
[[Category:Psychedelic tryptamines]] |
||
[[Category:Diisopropylamino compounds]] |
|||
{{Psychoactive-stub}} |
{{Psychoactive-stub}} |
||
[[fa:۴،۵-امدیاو-دیپیتی]] |
Latest revision as of 00:26, 25 January 2023
Clinical data | |
---|---|
Other names | 4,5-Methylenedioxy-N,N-diisopropyltryptamine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H24N2O2 |
Molar mass | 288.391 g·mol−1 |
3D model (JSmol) | |
| |
|
4,5-MDO-DiPT, or 4,5-methylenedioxy-N,N-diisopropyltryptamine, is a lesser-known psychedelic drug. It is the 4,5-methylenedioxy analog of DiPT. 4,5-MDO-DiPT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), 4,5-MDO-DiPT produces slight LSD-like effects after several hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of 4,5-MDO-DiPT.
See also
[edit]External links
[edit]